Reading is good for you...
Reading about what's good for you is even better.
December 18, 2023
December 14, 2023
August 8, 2022
Get your Remsima delivered at your door for FREE
Remsima (Infliximab) belongs to the class of medications called biological response modifiers ("biologics") or TNF blockers. It is used to treat: active ankylosing spondylitis in adults who have not responded to other therapies or who have experienced unacceptable side effects with other therapies active Psoriatic Arthritis in adults moderate-to-severe chronic plaque psoriasis in adults (after phototherapy has been shown ineffective or inappropriate) moderate-to-severe Rheumatoid Arthritis in adults when used in combination with Methotrexate fistulating Crohn's Disease in adults who have not responded to other therapies moderate-to-severe active Crohn's disease in adults s who have not responded to other therapies moderate-to-severe active Ulcerative Colitis in adults who have not responded to other therapies If you have one of these conditions, your body overproduces a protein called tumour necrosis factor (TNF), which causes pain, inflammation, and damage.
We accept all insurance plan
**Actual price will depend on the insurance coverage in your province
Remsima (Infliximab) belongs to the class of medications called biological response modifiers ("biologics") or TNF blockers. It is used to treat:
If you have one of these conditions, your body overproduces a protein called tumour necrosis factor (TNF), which causes pain, inflammation, and damage. Remsima (Infliximab) blocks the production of TNF and decreases the inflammation in the joints and on the skin. You may start to notice an improvement in symptoms about 2 weeks after starting treatment.
Your doctor may have suggested Remsima (Infliximab) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given Remsima (Infliximab), speak to your doctor. Do not stop using Remsima (Infliximab) without consulting your doctor.
Do not give Remsima (Infliximab) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take Remsima (Infliximab) if their doctor has not prescribed it.
The recommended dose of Remsima (Infliximab) depends on the condition being treated and varies according to body weight.
It is injected intravenously (into a vein) by a health care professional, usually in a clinical setting such as a hospital clinic, over several hours. This process is called an intravenous infusion. You should keep all your appointments and follow-ups as recommended by your doctor.
The appropriate dose for the following conditions is usually given 2 and 6 weeks after the first dose, then every 8 weeks thereafter:
For ankylosing spondylitis, the appropriate dose is usually given 2 and 6 weeks after the first dose, then every 6 to 8 weeks thereafter.
It is important to receive Remsima (Infliximab) exactly as recommended by your doctor. If you miss an appointment to receive Remsima (Infliximab), contact your doctor as soon as possible to reschedule your appointment.
Many things can affect the dose and schedule of medication that a person needs, such as body weight, other medical conditions, and other medications. Your doctor may choose a schedule different from the one above.
Remsima (Infliximab) must be refrigerated at 2°C to 8°C (do not freeze it) and kept out of the reach of children. Remsima (Infliximab) does not contain preservatives and must be mixed with sterile water for injection before IV infusion. Once the powder has been mixed, it should be used within 3 hours.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Remsima (Infliximab). If you are concerned about side effects, discuss the risks and benefits of Remsima (Infliximab) with your doctor.
The following side effects have been reported by at least 1% of people taking Remsima (Infliximab). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Remsima (Infliximab).
Remsima is no longer being manufactured for sale in Canada. For brands that may still be available, search under Remsima (Infliximab). This article is being kept available fro reference purposes only. If you are using Remsima (Infliximab), speak with your doctor or pharmacist for information about your treatment options.
You should not use Remsima (Infliximab) if you:
There may be an interaction between Remsima (Infliximab) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Remsima (Infliximab). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Remsima (Infliximab).
Allergic reactions: In rare cases, some people may develop an allergic reaction to Remsima (Infliximab). Signs of an allergic reaction include a severe rash, hives, swollen face or throat, or difficulty breathing. If these occur, contact your doctor immediately.
Blood disorders: Rarely, people taking Remsima (Infliximab) have become deficient in certain types of blood cells. This may lead to problems with blood clotting, the immune system, or the transport of oxygen through the body. Contact your doctor immediately if you develop a fever, easy bruising, paleness, or bleeding while taking Remsima (Infliximab).
Cancer: Compared to the general population, people taking Remsima (Infliximab) have a slightly greater risk of developing a cancer of the immune system (known as lymphoma). However, the risk of developing this type of cancer is still rare.
In general, people with severe rheumatoid arthritis and Crohn's disease who take medications that suppress the immune system over long periods of time may also have a higher risk of developing lymphoma, even if they don't take Remsima (Infliximab). Contact your doctor if you develop symptoms of lymphoma (such as fatigue, weight loss, fever, swollen glands, night sweats, and itching). (Note though that these may also be symptoms of other conditions.)
Some children and young adults with Crohn's disease who were receiving Remsima (Infliximab) have developed hepatosplenic T-cell lymphoma, a rare type of cancer that is often fatal. Talk to your doctor if you have any concerns.
Other forms of cancer, such as cervical and certain skin cancers, have also been seen in people who are taking Remsima (Infliximab). Talk to your doctor about the risks and benefits of using Remsima (Infliximab).
Heart failure: Remsima (Infliximab) may worsen congestive heart failure. If you have mild heart failure you should be closely monitored by your doctor while taking Remsima (Infliximab). If you notice symptoms of congestive heart failure (such as swelling of the hands or feet and difficulty breathing), contact your doctor immediately. People with moderate or severe congestive heart failure should not take Remsima (Infliximab).
Hepatitis B: People infected with hepatitis B (an infection that can damage the liver) may have a relapse of their condition while taking Remsima (Infliximab). If you are at risk for hepatitis B, your doctor may want to test you for this infection before starting treatment with Remsima (Infliximab) and will follow your condition closely while you are taking the medication. If you notice symptoms of a liver problem (see below), contact your doctor immediately.
Immune system disorders: Some people who take Remsima (Infliximab) have developed lupus-like syndrome, an autoimmune disease (a condition where the body is attacked by its own immune system). Symptoms of lupus-like syndrome include chest pain, joint pain, difficulty breathing, and a skin rash (usually on the cheeks and arms) that is sensitive to the sun. If you develop these symptoms, contact your doctor as soon as possible.
Infections: Remsima (Infliximab) can increase the risk of developing an infection, including serious infections such as sepsis, pneumonia, and tuberculosis. Before starting Remsima (Infliximab) treatment, your doctor may test to see if you have tuberculosis. If you notice signs of an infection such as fever, chills, pain, swelling, coughing or pus, contact your doctor as soon as possible. Remsima (Infliximab) should also not be started while you have an active infection.
Tell your doctor if you have a history of infections that keep coming back, or other conditions that might increase your risk of infections (e.g., Diabetes) or have visited or lived in areas where there is a greater risk of certain kinds of fungal infection (e.g., blastomycosis). While you are taking Remsima (Infliximab), your doctor will monitor you for signs of infection.
Liver problems: Very rarely, people taking Remsima (Infliximab) may experience liver problems. Symptoms of liver problems include abdominal pain, dark urine, fatigue, loss of appetite, and yellow eyes or skin. If you notice these symptoms, contact your doctor immediately.
Nervous system disorders: Rarely, Remsima (Infliximab) may increase the risk of problems with the nervous system or cause existing problems to get worse. If you experience confusion, seizures, vision changes, tingling or numbness, or weakness in your arms or legs while taking Remsima (Infliximab), contact your doctor immediately.
Vaccines: Live vaccines (e.g., BCG, yellow fever) are not recommended for people taking Remsima (Infliximab). Talk to your doctor if you need any vaccinations while taking Remsima (Infliximab). Children with Crohn's should complete the recommended vaccination schedule before receiving their first dose of Remsima (Infliximab).
Pregnancy: Remsima (Infliximab) is not recommended for use during pregnancy as it crosses the placenta and the effects on the developing baby are not known. Women who may become pregnant should use an effective method of birth control while they are taking Remsima (Infliximab) and for at least 6 months after the last treatment.
Breast-feeding: It is not known if Remsima (Infliximab) passes into breast milk. Women should not breast-feed while they are taking Remsima (Infliximab) and should not start breast-feeding until at least 6 months after the last treatment.
Children: The safety and effectiveness of Remsima (Infliximab) have not been established for children.
Seniors: Seniors may be more likely to experience serious infections with Remsima (Infliximab). Talk to your doctor about the risks and benefits of using Remsima (Infliximab).
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
December 18, 2023
December 14, 2023
August 8, 2022